Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I/Ib Study of P1446A-05 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).

NCT02117336 is registered in ClinicalTrials.gov with Piramal Enterprises Limited as lead sponsor.

NCT NCT02117336
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02117336 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I/Ib Study of P1446A-05 in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL).
Lead sponsor
Piramal Enterprises Limited
Phase
Phase 1
Overall status
Suspended
Start date
June 30, 2014
Completion date
March 31, 2017
Enrollment
36 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

relapsed/refractory chronic lymphocytic leukemia (cll)